Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
60.7 USD | +0.73% | +13.10% | -23.13% |
Financials (USD)
Sales 2024 * | 370B | Sales 2025 * | 387B | Capitalization | 76.2B |
---|---|---|---|---|---|
Net income 2024 * | 7.38B | Net income 2025 * | 8.69B | EV / Sales 2024 * | 0.34 x |
Net Debt 2024 * | 49.19B | Net Debt 2025 * | 45.81B | EV / Sales 2025 * | 0.32 x |
P/E ratio 2024 * |
10.7
x | P/E ratio 2025 * |
9.04
x | Employees | 259,500 |
Yield 2024 * |
4.38% | Yield 2025 * |
4.54% | Free-Float | 70.66% |
Latest transcript on CVS Health Corporation
1 day | +0.73% | ||
1 week | +13.10% | ||
Current month | +1.85% | ||
1 month | +8.59% | ||
3 months | -17.65% | ||
6 months | -14.53% | ||
Current year | -23.13% |
Managers | Title | Age | Since |
---|---|---|---|
Karen Lynch
CEO | Chief Executive Officer | 61 | 18-11-27 |
Thomas Cowhey
DFI | Director of Finance/CFO | 51 | 22-01-31 |
Tilak Mandadi
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-24 |
Members of the board | Title | Age | Since |
---|---|---|---|
Anne Finucane
BRD | Director/Board Member | 71 | 11-01-19 |
Fernando Aguirre
BRD | Director/Board Member | 66 | 18-11-27 |
Mary Schapiro
BRD | Director/Board Member | 68 | 17-05-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.92% | 17 M€ | +8.10% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-05 | 60.7 | +0.73% | 8,933,039 |
24-06-04 | 60.26 | +0.08% | 12,873,084 |
24-06-03 | 60.21 | +1.02% | 17,087,324 |
24-05-31 | 59.6 | +6.35% | 22,366,748 |
24-05-30 | 56.04 | +4.42% | 16,154,336 |
Delayed Quote Nyse, June 05, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-23.13% | 75.65B | |
+24.47% | 86.96B | |
+0.49% | 26.97B | |
+5.59% | 17.89B | |
-12.89% | 16.58B | |
+3.49% | 15.73B | |
+76.87% | 13.01B | |
+79.38% | 12.92B | |
+38.44% | 12.57B | |
+3.19% | 12.5B |
- Stock Market
- Equities
- CVS Stock